Papillary thyroid cancer
Papillary Thyroid Cancer
Introduction
Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, characterized by its growth in small, finger-like projections. It typically develops in the follicular cells of the thyroid gland and is known for its slow progression. PTC is more prevalent in women than men and often occurs before the age of 45.
Characteristics
PTC generally grows slowly and may develop in one or both lobes of the thyroid gland. It is known for its distinctive papillary structures and is often associated with a good prognosis when diagnosed early.
Risk Factors
Risk factors for PTC include:
- Gender, with a higher prevalence in women.
- Age, with a common occurrence before age 45.
- Genetic predispositions.
- Exposure to ionizing radiation, especially during childhood.
Symptoms
In its early stages, PTC may not cause any symptoms. As it progresses, symptoms can include:
- A lump in the neck.
- Hoarseness or voice changes.
- Difficulty swallowing or breathing.
- Swollen lymph nodes in the neck.

Diagnosis
Diagnosis of PTC typically involves:
- Physical examination.
- Blood tests to assess thyroid function.
- Imaging tests, such as ultrasound.
- Fine-needle aspiration biopsy for definitive diagnosis.
Treatment
Treatment options for PTC depend on the stage and may include:
- Surgery to remove part or all of the thyroid gland.
- Radioactive iodine therapy.
- Thyroid hormone therapy.
- Radiation therapy or chemotherapy in advanced cases.
Prognosis
The prognosis for PTC is generally favorable, especially for patients diagnosed at an early stage. Regular follow-up and monitoring are essential for managing potential recurrences or metastasis.
Research and Advances
Ongoing research in the field of thyroid cancer includes the development of targeted therapies and improved diagnostic techniques.
External Links
- [Link to a medical resource on papillary thyroid cancer]
- [Link to a patient support group for thyroid cancer]
References
<references/>
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


